Amgen Stock Increased by Nearly 5% Today

On Tuesday, Amgen (NASDAQ: AMGN) reached a one-year high, driven by a stronger-than-expected quarterly earnings report and an analyst’s price target increase. Deutsche Bank’s James Shin raised the stock’s target to $285 from $280, contributing to nearly a 5% gain in share price, although his recommendation remains a hold. The stock closed just $0.10 shy of its peak. This momentum reflects investor confidence following the earnings results.

Want More Context? 🔎